PANDA Trials2019-12-02T03:04:46+08:00

PANDA Trials

The PANDA trials evaluate the clinical performance
of the BuMA Drug Eluting Stent in a variety of
clinical scenarios.

Study Design

Study Results

Study Design

Study Results

Study Design

Clinical Results

Study Design

Study Results

Study Design

Study Results

Bibliography

  1. Xin Cheng, Rui Tian, Guo-zhon Wang, Dong-mei Shi, Zhi-jian Wang, Yun-peng Chi, Wen-long Dai, et al. 2013. “A Perspective Multicenter Parallel Controlled of BuMA vs. Endeavor Clinical Trail Program.” Chinese Journal of Interventional Cardiology 21 (3): 137–41.   https://doi.org/10.3969/j.issn.1004-8812.2013.03.001
  2. Jie Qian, Yao Jun Zhang, Bo Xu, Yue Jin Yang, Hong Bing Yan, Zhong Wei Sun, Ye Lin Zhao, et al. 2014. “Optical Coherence Tomography Assessment of a PLGA-Polymer with Electro-Grafting Base Layer versus a PLA-Polymer Sirolimus-Eluting Stent at Three-Month Follow-up: The BuMA-OCT Randomised Trial.” EuroIntervention 10 (7): 806–14.   https://doi.org/10.4244/EIJY14M07_17
  3. Bo Xu, Runlin Gao, Yuejin Yang, Xuebin Cao, Lei Qin, Yi Li, Zhanquan Li, et al. 2016. “Biodegradable Polymer-Based Sirolimus-Eluting Stents with Differing Elution and Absorption Kinetics the PANDA III Trial.” Journal of the American College of Cardiology 67 (19): 2249–58.   https://doi.org/10.1016/j.jacc.2016.03.475
  4. Changdong Guan, Bo Xu, Shubin Qiao, Lei Qin, Yi Li, Zhanquan Li, Yong Guo, Zhongwei Sun, Lei Song, and Runlin Gao. 2017. “Comparison of Two Biodegradable-Polymer-Based Sirolimus-Eluting Stents with Varying Elution and Absorption Kinetics in Patients with Acute Myocardial Infarction: A Subgroup Analysis of the PANDA III Trial.” Catheterization and Cardiovascular Interventions 89: 520–27.   https://doi.org/10.1002/ccd.26918.
  5. Sida Jia, Changdong Guan, Jinqing Yuan, Runlin Gao, Martin Leon, and Bo Xu. 2018. “TCT-666: Safety Evaluation of the Biodegradable Polymer-Based Sirolimus-Eluting Stent with Faster Drug Eluting Rate and Polymer Absorption Kinetics in Complex Patient and Lesion Subgroup of the PANDA III Trial.” J Am Coll Cardiol 72 (13, Suppl B.): 7640.   https://doi.org/10.1016/j.jacc.2018.08.1876

GB-30002-01  Rev. 00